Boston Scientific Corp

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC BSX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

10,936,957

Value ($000)

1,042,839

Weight

0.2%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,042,839	0.2%	10,936,957	12/31/2025
2025 Q3	11/14/2025	1,071,820	0.2%	10,978,385	9/30/2025
2025 Q2	8/14/2025	1,369,485	0.3%	12,750,070	6/30/2025
2025 Q1	5/19/2025	1,139,938	0.3%	11,299,942	3/31/2025
2024 Q4	2/14/2025	968,172	0.2%	10,839,362	12/31/2024
2024 Q3	11/14/2024	765,086	0.2%	9,129,901	9/30/2024
2024 Q2	8/14/2024	731,392	0.2%	9,497,358	6/30/2024
2024 Q1	5/15/2024	501,579	0.2%	7,323,384	3/31/2024
2023 Q4	2/14/2024	459,285	0.2%	7,944,728	12/31/2023
2023 Q3	11/13/2023	405,399	0.2%	7,678,013	9/30/2023
2023 Q2	8/11/2023	362,037	0.2%	7,236,391	6/30/2023
2023 Q1	5/15/2023	362,037	0.2%	7,236,391	3/31/2023
2022 Q4	2/14/2023	377,225	0.2%	8,152,692	12/31/2022
2022 Q3	11/14/2022	216,780	0.1%	5,597,212	9/30/2022
2022 Q2	8/12/2022	210,564	0.1%	5,649,693	6/30/2022
2022 Q1	5/16/2022	251,016	0.1%	5,667,544	3/31/2022
2021 Q4	2/14/2022	241,879	0.1%	5,693,960	12/31/2021
2021 Q3	11/15/2021	275,888	0.1%	6,358,324	9/30/2021
2021 Q2	8/16/2021	287,308	0.1%	6,719,082	6/30/2021
2021 Q1	5/14/2021	316,917	0.1%	8,199,663	3/31/2021
2020 Q4	3/1/2021	278,486	0.1%	7,746,495	12/31/2020
2020 Q3	11/13/2020	266,155	0.1%	6,965,576	9/30/2020
2020 Q2	8/14/2020	236,439	0.1%	6,734,222	6/30/2020
2020 Q1	5/15/2020	173,924	0.1%	5,330,197	3/31/2020
2019 Q4	2/14/2020	200,879	0.1%	4,442,255	12/31/2019
2014 Q1	5/23/2014	59,151	0.1%	4,375,119	3/31/2014
2013 Q4	1/31/2014	50,315	0.1%	4,185,912	12/31/2013